Acarbose
Active ingredient description
Acarbose is an alpha-glucosidase inhibitors, used in the treatment of diabetes. Inhibitors of a-glucosidase retard the breakdown of carbohydrates in the food and reduce the increase in blood glucose levels, which occurs after each meal.
Medicine classification
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
Medicines
Acarbose is the active ingredient of these drugs:
New Zealand
Tunisia
Hong Kong
Italy
New Zealand
Poland
Brazil
Tunisia
Tunisia
Hong Kong
Tunisia
Singapore
Australia Austria Brazil Canada Estonia
France Tunisia
Tunisia
Australia
Tunisia
United States
Hong Kong
Product monographs
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):